VCII — Stock Film
STOCK FILMSCENE 1/8VCII · $0.0001
Stock Expert AI presents
VCII
ViviCells International, Inc
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
ViviCells International, Inc. A quick introduction.

On the stock market since 1998, it operates in electricity, water and gas. It has 16 employees. Now — the numbers.

on the stock market since 1998
16 employees
$11K market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales have been shrinking.

An average decline of 100% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$4.2M
1999
$0
2016
$0
2017
$0
2018
$0
2019
THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

THE BRIGHT SIDE

Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $5K against $0 in annual sales.

2
THE RISKS · 2/2
Trading under $1

The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, VCII sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: VCII is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film